Banka BioLoo Limited (NSE:BANKA)
India · Delayed Price · Currency is INR 81.80
+3.87 (4.97%)
Sep 11, 2026, 3:29 PM IST
Banka BioLoo Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 565.03 | 570.92 | 541.74 | 499.96 | 423.5 | 387.51 |
Other Revenue | - | - | - | -0 | - | - |
| 565.03 | 570.92 | 541.74 | 499.96 | 423.5 | 387.51 | |
Revenue Growth | 7.77% | 5.39% | 8.36% | 18.05% | 9.29% | 27.23% |
Cost of Revenue | 394 | 421.24 | 453.24 | 403.04 | 293.34 | 246.27 |
Gross Profit | 171.03 | 149.68 | 88.5 | 96.92 | 130.15 | 141.24 |
Selling, General & Admin | 69.01 | 68.76 | 57.97 | 36.21 | 4.14 | 4.05 |
Other Operating Expenses | 35.31 | 28.95 | 59.21 | 23.29 | 65.6 | 81.47 |
Operating Expenses | 134.43 | 125.73 | 142.48 | 81.39 | 84.57 | 94.93 |
Operating Income | 36.6 | 23.96 | -53.98 | 15.54 | 45.59 | 46.31 |
Interest Expense | -39.56 | -36.15 | -33.82 | -22.76 | -15 | -16.41 |
Interest & Investment Income | - | 4 | 2.51 | 3.78 | 5.56 | 3.91 |
Earnings From Equity Investments | 0.23 | 0.29 | 0.28 | -0.21 | 0.06 | 0.27 |
Currency Exchange Gain (Loss) | - | - | 0.62 | - | - | - |
Other Non Operating Income (Expenses) | 3.43 | 7.67 | -3.74 | -1.99 | 0.03 | -0.97 |
EBT Excluding Unusual Items | 0.7 | -0.23 | -88.13 | -5.63 | 36.24 | 33.11 |
Impairment of Goodwill | - | - | -3.15 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.04 | - | - | -0.03 |
Other Unusual Items | -2.95 | -2.42 | - | - | - | - |
Pretax Income | -2.25 | -2.65 | -91.24 | -5.63 | 36.24 | 33.08 |
Income Tax Expense | -5.77 | -6.58 | -2.15 | 1.08 | 10.85 | 2.01 |
Earnings From Continuing Operations | 3.52 | 3.93 | -89.09 | -6.71 | 25.39 | 31.08 |
Minority Interest in Earnings | - | -0.42 | -0.06 | 0.19 | - | - |
Net Income | 3.52 | 3.51 | -89.15 | -6.53 | 25.39 | 31.08 |
Net Income to Common | 3.52 | 3.51 | -89.15 | -6.53 | 25.39 | 31.08 |
Net Income Growth | - | - | - | - | -18.30% | 40.95% |
Shares Outstanding (Basic) | 39 | 11 | 11 | 11 | 11 | 10 |
Shares Outstanding (Diluted) | 39 | 11 | 11 | 11 | 11 | 10 |
Shares Change | - | 1.99% | -1.16% | 1.67% | 4.85% | 0.18% |
EPS (Basic) | 0.09 | 0.32 | -8.21 | -0.60 | 2.35 | 3.02 |
EPS (Diluted) | 0.09 | 0.32 | -8.21 | -0.60 | 2.34 | 3.02 |
EPS Growth | - | - | - | - | -22.44% | 40.98% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -49.45 | -36.13 | -72.07 | 9.4 | -36 |
Free Cash Flow Per Share | - | -4.47 | -3.33 | -6.56 | 0.87 | -3.50 |
Gross Margin | 30.27% | 26.22% | 16.34% | 19.39% | 30.73% | 36.45% |
Operating Margin | 6.48% | 4.20% | -9.96% | 3.11% | 10.76% | 11.95% |
Profit Margin | 0.62% | 0.61% | -16.46% | -1.31% | 6.00% | 8.02% |
Free Cash Flow Margin | - | -8.66% | -6.67% | -14.41% | 2.22% | -9.29% |
EBITDA | 66.72 | 48.11 | -34.37 | 31.72 | 54.74 | 51.93 |
EBITDA Margin | 11.81% | 8.43% | -6.35% | 6.35% | 12.93% | 13.40% |
D&A For EBITDA | 30.12 | 24.15 | 19.61 | 16.19 | 9.15 | 5.62 |
EBIT | 36.6 | 23.96 | -53.98 | 15.54 | 45.59 | 46.31 |
EBIT Margin | 6.48% | 4.20% | -9.96% | 3.11% | 10.76% | 11.95% |
Effective Tax Rate | - | - | - | - | 29.94% | 6.07% |
Revenue as Reported | 568.45 | 583.86 | 545.01 | 504.91 | 430.51 | 392.05 |
Advertising Expenses | - | 1.07 | 0.57 | 0.51 | 1.94 | 0.3 |